Check Point Software Technologies Expands Current Share Repurchase Program

Check Point Software Technologies Ltd. (CHKP) announced on July 25 that the company’s Board of Directors authorized a major expansion of the current share repurchase program. The updated repurchase plan is effective immediately and increases the quarterly repurchase 30% to $325 million in outstanding shares. The overall repurchase plan increased 100% to a total of […]

Read more...

Fidelity National Financial Announces New Stock Repurchase Program

On July 17, Fidelity National Financial, Inc. (FNF) announced that the company’s Board of Directors approved a new stock repurchase program. The new repurchase program replaces the previous stock repurchase program, which expires on July 31. The company repurchased a total of 10.6 million shares of stock with the previous program. The new stock repurchase […]

Read more...

Reata Pharmaceuticals Reports Positive Phase 2 Results From Two Clinical Trials

On July 23, Reata Pharmaceuticals, Inc. (RETA) announced results from two Phase 2 clinical trials of bardoxolone in patients with chronic kidney disease. The one-year results for the Phase 2 portion of CARDINAL, a study of bardoxolone in patients with chronic kidney disease due to Alport syndrome, found that patients had no drug-related negative side […]

Read more...

Capstone Turbine Announces Contract Renewals Totaling 4.4MW

Capstone Turbine Corporation (CPST) announced on July 11 that the company has secured nine separate Factory Protection Plan (FPP) aftermarket long-term service contract renewals from a major U.S. oil and gas producer. The contracts cover a total of 4.4 MWs. Capstone Turbine is the world’s leading clean technology manufacturer of microturbine energy systems.   Sonal […]

Read more...

Harris Corporation Awarded $1.5 Billion in US Geospatial Intelligence Contracts

On July 10, Harris Corporation (HRS) reported that the company has been awarded three multi-award IDIQ contracts by the National Geospatial-Intelligence Agency (NGA). Harris will create, manage, and distribute high-quality geospatial intelligence for the US intelligence community and military. The contract covers services for up to 10 years and totals $1.5 billion.   Sonal sent […]

Read more...

Aclaris Therapeautics Reports Positive Phase 2 Clinical Trial Results

On June 28, Aclaris Therapeutics (ACRS) reported positive interim results from its Phase 2 clinical trial of AA-202 Topical. The drug is an investigational topical to treat two of the more severe variants of Alopecia Areata. Patients did not experience any treatment-related serious adverse events, and results for the full patient sample will be reported […]

Read more...

IsoRay Receives FDA 510(k) Clearance for GammaTileTM Therapy

On July 9, IsoRay, Inc. (ISR) and GT Medical Technologies, Inc. announced they received FDA 510(k) regulatory clearance for their brachytherapy technology, known as GammaTileTMTherapy. The therapy incorporates proprietary Cesium-131 seeds within customizable collagen-based carriers to treat recurrent brain tumors. The two companies previously executed a ten-year collaborative development agreement.   Sonal detected the event […]

Read more...

AZZ Awarded Contract in China as part of Highest Transmission Capacity Project in the World

AZZ, Inc. (AZZ) announced on June 29 that the company was awarded a contract in the People’s Republic of China to produce approximately 7,431 meters of Ultra High Voltage 1100KV Gas Insulated Line for the Cross Yangtze River Sutong Underground Tunnel Project. The contract is with SDEE Hitachi High Voltage Switchgear and Pinggao Group Company […]

Read more...